Healthcare provider profile · identity verified

Jay C Thomas

Family Practice · ROME, GA · NPI 1013939339

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	545	132
Atorvastatin Calcium	Atorvastatin Calcium	427	113
Pravastatin Sodium	Pravastatin Sodium	406	83
Gabapentin	Gabapentin	355	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	338	43
Metformin Hcl	Metformin Hcl	305	68
Omeprazole	Omeprazole	296	68
Levothyroxine Sodium	Levothyroxine Sodium	283	64
Lisinopril	Lisinopril	278	69
Fenofibrate	Fenofibrate	277	55
Tramadol Hcl	Tramadol Hcl	263	48
Metoprolol Succinate	Metoprolol Succinate	260	57
Lorazepam	Lorazepam	244	34
Pantoprazole Sodium	Pantoprazole Sodium	244	63
Furosemide	Furosemide	233	57
Alprazolam	Alprazolam	219	32
Albuterol Sulfate Hfa	Albuterol Sulfate	205	47
Metoprolol Tartrate	Metoprolol Tartrate	200	38
Hydrochlorothiazide	Hydrochlorothiazide	181	47
Citalopram Hbr	Citalopram Hydrobromide	170	32
Zolpidem Tartrate	Zolpidem Tartrate	158	23
Losartan Potassium	Losartan Potassium	154	41
Potassium Chloride	Potassium Chloride	140	31
Hydralazine Hcl	Hydralazine Hcl	127	26
Famotidine	Famotidine	125	30
Pregabalin	Pregabalin	124	20
Glimepiride	Glimepiride	123	21
Tamsulosin Hcl	Tamsulosin Hcl	123	33
Rosuvastatin Calcium	Rosuvastatin Calcium	122	35
Sertraline Hcl	Sertraline Hcl	122	27
Trazodone Hcl	Trazodone Hcl	122	22
Bupropion Xl	Bupropion Hcl	117	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	112	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	111	20
Benazepril Hcl	Benazepril Hcl	108	24
Diazepam	Diazepam	107	14
Meloxicam	Meloxicam	106	25
Clopidogrel	Clopidogrel Bisulfate	105	26
Fluticasone Propionate	Fluticasone Propionate	103	31
Clonazepam	Clonazepam	94	12
Ozempic	Semaglutide	93	12
Atenolol	Atenolol	92	22
Montelukast Sodium	Montelukast Sodium	89	19
Azithromycin	Azithromycin	86	71
Ezetimibe	Ezetimibe	85	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	78	13
Eliquis	Apixaban	77	18
Fluoxetine Hcl	Fluoxetine Hcl	77	13
Simvastatin	Simvastatin	77	22
Carvedilol	Carvedilol	72	20
Diclofenac Sodium	Diclofenac Sodium	69	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	22
Warfarin Sodium	Warfarin Sodium	64	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	63	39
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	61	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	17
Triamcinolone Acetonide	Triamcinolone Acetonide	59	20
Esomeprazole Magnesium	Esomeprazole Magnesium	56	11
Quetiapine Fumarate	Quetiapine Fumarate	56	13
Tizanidine Hcl	Tizanidine Hcl	56	suppressed
Allopurinol	Allopurinol	54	14
Buspirone Hcl	Buspirone Hcl	54	11
Temazepam	Temazepam	53	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	52	14
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Lovastatin	Lovastatin	50	suppressed
Spironolactone	Spironolactone	50	suppressed
Xarelto	Rivaroxaban	50	suppressed
Etodolac	Etodolac	49	13
Hydroxyzine Hcl	Hydroxyzine Hcl	49	suppressed
Synthroid	Levothyroxine Sodium	49	11
Escitalopram Oxalate	Escitalopram Oxalate	48	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	13
Doxazosin Mesylate	Doxazosin Mesylate	44	suppressed
Ventolin Hfa	Albuterol Sulfate	44	13
Trulicity	Dulaglutide	43	suppressed
Metformin Hcl Er	Metformin Hcl	42	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	12
Jardiance	Empagliflozin	40	suppressed
Estradiol	Estradiol	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	22
Prednisone	Prednisone	38	26
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Alendronate Sodium	Alendronate Sodium	36	suppressed
Topiramate	Topiramate	36	suppressed
Cefdinir	Cefdinir	35	28
Fluconazole	Fluconazole	34	23
Irbesartan	Irbesartan	32	suppressed
Lamotrigine	Lamotrigine	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	31	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Amoxicillin	Amoxicillin	29	25
Methylprednisolone	Methylprednisolone	28	26
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Baclofen	Baclofen	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	13
Tradjenta	Linagliptin	22	suppressed
Insulin Lispro	Insulin Lispro	21	suppressed
Methocarbamol	Methocarbamol	21	13
Mirtazapine	Mirtazapine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Glipizide	Glipizide	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Ubrelvy	Ubrogepant	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Vascepa	Icosapent Ethyl	17	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Primidone	Primidone	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Advocate Pen Needles	Pen Needle, Diabetic	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Bystolic	Nebivolol Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error